Patient | Age | Grade | Stage | ER status | PR status | HER2 status |
---|---|---|---|---|---|---|
16H | [50–60) | 3 | III | P | P | N |
16 J | [40–50) | 1 | II | P | P | N |
16 K | [40–50) | 2 | II | P | P | N |
16 W | [70–80) | 2 | I | P | N | N |
17E | [60–70) | 2 | I | P | P | N |
18Y | [40–50) | 2 | I | P | P | P |
19A | [50–60) | 2 | II | P | P | N |
19D | [80–90) | 3 | III | P | P | N |
19G | [50–60) | 2 | II | P | N | N |
19 K | [50–60) | 2 | II | P | P | N |
19 M | [40–50) | 3 | I | P | P | N |
19O | [50–60) | 2 | II | P | P | N |